|
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a3.htm
www.cdc.gov/mmwr/pdf/wk/mm6050.pdf
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm
www.cdc.gov/mmwr/pdf/rr/rr6002.pdf
FDA Licensure of Bivalent Human Papillomavirus
Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination
Recommendations from the Advisory Committee on Immunization Practices (ACIP)
May 28, 2010; 59(20):626-629
www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a4.htm
www.cdc.gov/mmwr/PDF/wk/mm5920.pdf
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for
Use in Males and Guidance from the Advisory Committee on Immunization Practices
(ACIP) Weekly
MMWR, May 28, 2010; 59(20):630-632
www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a5.htm
www.cdc.gov/mmwr/PDF/wk/mm5920.pdf ACIP Recommendations: Quadrivalent Human
Papillomavirus Vaccine
MMWR, March 12, 2007; 56(Early Release):1-24
www.cdc.gov/mmwr/preview/mmwrhtml/rr56e312a1.htm?s_cid=rr56e312a1_e
www.cdc.gov/mmwr/pdf/rr/rr56e312.pdf
 |
American
Academy of Pediatrics |
|
